Creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage
C the Signs has raised €14M across 2 funding rounds from 5 investors, most recently a round in Jan 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-01-30 | Other | €7.7M | Khosla Ventures | View deal → |
| 2022-02-07 | Other | €5.9M | Acequia Capital,Angel Investors,Ataraxia,MMC Ventures | View deal → |
